Clinical Trials for ORIC Pharmaceuticals

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: ORIC Pharmaceuticals

Clinical Trials (3)

NCT06816992
ORIC-114 in Combination with Subcutaneous Amivantamab in Patients with EGFR Exon20 Insertion Mutant NSCLC
PHASE1Recruiting
76 participants
Started: Feb 27, 2025 · Completed: May 31, 2027
4 conditions2 sponsors4 locations
NCT05413421
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
PHASE1Recruiting
250 participants
Started: Jun 1, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor27 locations
NCT05315700
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
PHASE1/PHASE2Recruiting
350 participants
Started: Mar 10, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor42 locations